Key Record Dates
ClinicalTrials.gov Identifier: | NCT05000450 |
---|---|
Brief Title: | Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma |
First Submitted : | August 4, 2021 |
First Submitted that Met QC Criteria : | August 4, 2021 |
First Posted : | August 11, 2021 |
Last Update Submitted that Met QC Criteria : | February 9, 2022 |
Last Update Posted : | February 11, 2022 |